Comparative safety and effectiveness of inhaled corticosteriods and beta-agonist for chronic asthma: a rapid review and network meta-analysis
Tricco AC, Ashoor HM, Zarin W, Thomas S, Hamid J, Yazdi F, Lillie E, Kealey R, Ghassemi M, Loyman RJ. Comparative safety and effectiveness of inhaled corticosteroids and beta-agonists for chronic asthma: a rapid review and network meta-analysis. 2014.
[sidebar] Commissioned and Funded by: Ontario Drug Policy Research Network (ODPRN) and Ontario Ministry of Health and Long-Term Care (OMHLTC)
[/no-bottom-margin]
Share Buttons [span][/span]
[ssba-buttons] [/sidebar] [sidebar-content]- Our results can be used by patients and physicians to tailor administration of these agents
- Commissioned by the Ontario Drug Policy Research Network to inform the listing of these agents by the Ontario Public Drug Program
- Fixed or adjustable dose combined inhalers with low dosage ICS+LABA, medium dosage ICS+LABA, or high dosage ICS+LABA had the greatest probability of decreasing the risk of moderate to severe exacerbations
- There were no significant differences in risk of cardiovascular disease or cardiovascular related mortality across all treatment groups
Related Projects:
[/sidebar-content]Category : KS Projects
Date : 03 Sep 2020